Catalyst Wire Dossier Catalyst Wire Dossier

TETA 4HCl

triethylenetetramine tetrahydrochloride
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TETA 4HCl, covering 2025-08-15 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily). [Phase 1]

See pricing